Caprolactam Chemicals Limited (BOM:507486)
India · Delayed Price · Currency is INR 40.50
+1.45 (3.71%)
At close: Aug 20, 2026
Caprolactam Chemicals Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 84.61 | 105.58 | 67.4 | 69.57 | 98.42 | 20.69 |
Other Revenue | - | - | - | 0 | - | - |
| 84.61 | 105.58 | 67.4 | 69.57 | 98.42 | 20.69 | |
Revenue Growth | 3.42% | 56.65% | -3.13% | -29.30% | 375.71% | -67.21% |
Cost of Revenue | 7.56 | 8.85 | 17.13 | 8.88 | 11.37 | 6.03 |
Gross Profit | 77.05 | 96.73 | 50.27 | 60.7 | 87.05 | 14.66 |
Selling, General & Admin | 4.96 | 5.16 | 3.71 | 3.88 | 3.77 | 2.54 |
Other Operating Expenses | 42.33 | 46.89 | 31.32 | 33.37 | 36.51 | 13.8 |
Operating Expenses | 63.28 | 68.16 | 50.92 | 53.07 | 51.81 | 26.69 |
Operating Income | 13.77 | 28.56 | -0.65 | 7.62 | 35.23 | -12.03 |
Interest Expense | -7.14 | -7.19 | -6.29 | -4.98 | -5.68 | -2.76 |
Interest & Investment Income | - | - | 0.1 | 0.08 | 0.15 | 0.06 |
Other Non Operating Income (Expenses) | 0.28 | 0.28 | - | -0 | - | - |
EBT Excluding Unusual Items | 6.91 | 21.66 | -6.84 | 2.72 | 29.71 | -14.74 |
Pretax Income | 6.91 | 21.66 | -6.84 | 2.72 | 29.71 | -14.74 |
Income Tax Expense | 2.81 | 4.04 | 0.25 | 0.75 | 4.22 | -1.92 |
Net Income | 4.11 | 17.61 | -7.09 | 1.97 | 25.49 | -12.82 |
Net Income to Common | 4.11 | 17.61 | -7.09 | 1.97 | 25.49 | -12.82 |
Net Income Growth | - | - | - | -92.25% | - | - |
Shares Outstanding (Basic) | 5 | 5 | 5 | 5 | 5 | 5 |
Shares Outstanding (Diluted) | 5 | 5 | 5 | 5 | 5 | 5 |
Shares Change | 0.05% | -0.03% | - | - | - | - |
EPS (Basic) | 0.89 | 3.83 | -1.54 | 0.43 | 5.54 | -2.79 |
EPS (Diluted) | 0.89 | 3.83 | -1.54 | 0.43 | 5.54 | -2.79 |
EPS Growth | - | - | - | -92.25% | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | - | 1.82 | -22.35 | 1.7 | -12.98 | -17.06 |
Free Cash Flow Per Share | - | 0.40 | -4.86 | 0.37 | -2.82 | -3.71 |
Gross Margin | 91.07% | 91.62% | 74.59% | 87.24% | 88.45% | 70.84% |
Operating Margin | 16.28% | 27.05% | -0.96% | 10.96% | 35.80% | -58.15% |
Profit Margin | 4.85% | 16.68% | -10.51% | 2.84% | 25.90% | -61.97% |
Free Cash Flow Margin | - | 1.72% | -33.16% | 2.45% | -13.19% | -82.44% |
EBITDA | 29.98 | 44.7 | 15.24 | 23.45 | 46.76 | -1.68 |
EBITDA Margin | 35.43% | 42.34% | 22.61% | 33.70% | 47.51% | -8.14% |
D&A For EBITDA | 16.21 | 16.14 | 15.89 | 15.82 | 11.53 | 10.35 |
EBIT | 13.77 | 28.56 | -0.65 | 7.62 | 35.23 | -12.03 |
EBIT Margin | 16.28% | 27.05% | -0.96% | 10.96% | 35.80% | -58.15% |
Effective Tax Rate | 40.62% | 18.67% | - | 27.53% | 14.21% | - |
Revenue as Reported | 84.92 | 105.89 | 67.49 | 71.37 | 98.57 | 24.74 |